The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review

INTRODUCTION: This study aimed at evaluating the overall survival (OS) gain associated with human epidermal growth factor receptor 2 (HER2)-directed therapies in patients with metastatic breast cancer (mBC). METHODS: A bibliographic search was conducted in PubMed and Cochrane databases. Only phase I...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Breast Cancer Res
Main Authors: Mendes, Diogo, Alves, Carlos, Afonso, Noémia, Cardoso, Fátima, Passos-Coelho, José Luís, Costa, Luís, Andrade, Sofia, Batel-Marques, Francisco
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4650834/
https://ncbi.nlm.nih.gov/pubmed/26578067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0648-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki